CompoAtlas

Lipozene 10

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Falls dieses Produkt in Frankreich verkauft würde

Eine Tagesmenge wird nur bei ausdrücklicher oraler Dosierung für Erwachsene berechnet, die pro Tag und in einer zur Produktform passenden festen Einheit angegeben ist. Mehrdeutige Einheiten, Flüssigkeiten, Pulver und pädiatrische Dosen werden nicht hochgerechnet. Eine nicht berechnete Menge wird nicht mit Dosisgrenzwerten verglichen. Diese Analyse stellt weder eine Verkaufszulassung in Frankreich noch eine Sicherheits- oder Wirksamkeitsbewertung dar.

Zusammensetzung

Arzneilicher Inhaltsstoff und QuelleJe Dosiseinheit laut QuelleTäglich höchstens, Erwachsene
Biotine

Quelle : Biotine

75 microgrammesNicht berechnet
1,3,7-Triméthylxanthine

Quelle : Isolat

50 milligrammeNicht berechnet
Capsicum annuum

Quelle : Fruit

2,5 milligrammeNicht berechnet
Camellia sinensis

Quelle : leaf standardized extract

Stärke : 50 % Polyphenols

300 milligrammeNicht berechnet
Paullinia cupana

Quelle : Seed extract (standardized)

Stärke : 22 % Caffeine

62,5 milligrammeNicht berechnet
Cola Acuminata

Quelle : Seed extract (standardized)

Stärke : 10 % Caffeine

25 milligrammeNicht berechnet
Platycodon grandiflorus

Quelle : Extrait de racine

Extrakt : Extract Type TBA

Extraktionsverhältnis : 10:1

Trockenpflanzenäquivalent : 12,5 mg

1,25 milligrammeNicht berechnet
Camellia sinensis

Quelle : Feuille

35 milligrammeNicht berechnet
Vitamine B12

Quelle : Cyanocobalamine

1,5 microgrammesNicht berechnet
Vitamine B6

Quelle : Chlorhydrate de pyridoxine

0,3 milligrammeNicht berechnet
Glucomannane

Quelle : Amorphophallus konjac - tubercule

750 milligrammeNicht berechnet
Magnésium

Quelle : Oxyde de magnésium

40 milligrammeNicht berechnet
Riboflavine

Quelle : Riboflavine

0,425 milligrammeNicht berechnet
Chrome

Quelle : Citrate chromique

15 microgrammesNicht berechnet
Cuivre

Quelle : Gluconate de cuivre

500 microgrammesNicht berechnet
Calcium

Quelle : Phosphate de calcium, dibasique

125 milligrammeNicht berechnet
Folate

Quelle : Acide folique

100 microgrammesNicht berechnet
Iode

Quelle : Iodure de potassium

18,75 microgrammesNicht berechnet
Amorphophallus konjac

Quelle : Root tuber(s)

Stärke : 95 % Glucomannan

50 milligrammeNicht berechnet
Manganèse

Quelle : Manganous sulfate

0,25 milligrammeNicht berechnet
Molybdène

Quelle : Molybdate de sodium (VI)

9,375 microgrammesNicht berechnet
Niacinamide

Quelle : Niacinamide

5 milligrammeNicht berechnet
Acide pantothénique

Quelle : D-pantothénate de calcium

2,5 milligrammeNicht berechnet
Phosphore

Quelle : Phosphate de calcium, dibasique

98,5 milligrammeNicht berechnet
Sélénium

Quelle : Sélénométhionine

8,75 microgrammesNicht berechnet
Thiamine

Quelle : Chlorhydrate de thiamine

0,375 milligrammeNicht berechnet
Vitamine A

Quelle : Palmitate de vitamine A

Stärke : 375 UI

113,25 mcg EARNicht berechnet
Vitamine B12

Quelle : Cyanocobalamine

7,5 microgrammesNicht berechnet
Vitamine B6

Quelle : Chlorhydrate de pyridoxine

0,5 milligrammeNicht berechnet
Vitamine C

Quelle : Acide ascorbique

15 milligrammeNicht berechnet
Vitamine D

Quelle : Cholécalciférol

Stärke : 100 UI

2,5 microgrammesNicht berechnet
Vitamine E

Quelle : Acétate de d-alpha-tocophéryle

Stärke : 7,5 UI

5,025 mg ATNicht berechnet
Concentré de protéine de lactosérum

Quelle : Bos taurus (lait)

Stärke : 76 % Protein

14.473,7 milligrammeNicht berechnet
Zinc

Quelle : Oxyde de zinc

3,75 milligrammeNicht berechnet

Nicht arzneiliche Inhaltsstoffe

Acide stéarique, Gélatine, Carbonate de calcium, Silicate de magnésium, gomme de guar, Saveur, Oat hull fibre, Inuline, Cellulose, Saveur de chocolat, Cellulose microcristalline, Croscarmellose de sodium, Huile de tournesol, Maltodextrine, Sucralose, FD&C Blue #1, Pharmaceutical Glaze, Stéarate de magnésium, vanilla cream flavour, Dioxyde de titane, Poudre de cacao, D-Fructose, gomme acacia, Dioxyde de silicium

In Kanada empfohlene Dosen

BevölkerungsgruppeAlterMenge pro EinnahmeHäufigkeit
AdultesNon précisée2 Capsule3 Tous les jours
AdultesNon précisée2 CompriméNon précisée
AdultesNon précisée1 Portion(s)2 Tous les jours

In Kanada zugelassene Verwendungen

Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision, bones and teeth. Helps to build strong bones and teeth. Helps to maintain healthy skin and/or mucous membranes. Helps in normal function of the immune system. Helps in energy metabolism in the body. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in wound healing. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Source of/An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Source of/An antioxidant that helps (to): a) fight/ b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps to maintain immune function. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combines with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps in the process of normal cell division. Source of/An antioxidant that protects the fat in body tissues from oxidation. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Source of/An electrolyte for the maintenance of good health. Helps to maintain normal muscle function. Helps in the process of normal regulation of cell division and specialisation. Provides support for healthy glucose metabolism. Helps to maintain normal blood glucose levels. Helps to produce and repair connective tissue. Helps to maintain normal iron transport in the body. Helps in the function of the thyroid gland. Helps to maintain normal production of thyroid hormones. Helps in tissue formation. Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Helps in energy metabolism, tissue formation and bone development. Helps to maintain normal electrolyte balance. Source of/An antioxidant that helps protect against oxidative stress. Helps to maintain normal function of the thyroid gland. Helps to maintain healthy skin. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Helps to maintain healthy bones, hair, nail and/or skin.

Originaltext auf Englisch.

Overarching Claims:Lipozene, MetaboUp Plus and Lipozene Protein Plus have been designed to be used together to help temporarily support a feeling of fullness, increase thermogenesis and increase basal metabolic rate. Claims Specific to Lipozene: (Used in Herbal Medicine as a) bulk-forming laxative. (Used in Herbal Medicine to) promote(s) bowel movements by increasing bulk volume and water content. (Used in Herbal Medicine to) provide(s) gentle relief of constipation and/or irregularity. Helps to lower cholesterol levels (by reducing cholesterol absorption from the gastrointestinal tract). Helps to temporarily support a feeling of fullness. Contributing to healthy blood sugar levels. Helps reduce elevated total and LDL cholesterol levels. Helps support healthy blood sugar levels. Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals in a weight management program. Claims Specific to MetaboUp Plus: Helps the body to metabolize carbohydrates, fats and proteins. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Used (temporarily) as a mild diuretic. Source of antioxidants. Helps temporarily to increase thermogenesis. Helps temporarily to increase basal metabolic rate. Claims Specific to Lipozene Protein Plus: Workout supplement. Athletic support. Excellent source of protein for the maintenance of good health. Excellent source of protein which helps build and repair body tissues. Excellent source of protein which helps build antibodies. Source of amino acids involved in muscle protein synthesis. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of vitamins and minerals, factors in the maintenance of good health, in normal growth and development and support biological functions which play a key role in the maintenance of good health. Multi-vitamin/mineral supplement. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain cognitive functions. Helps to maintain the body's ability to metabolize nutrients. Helps to form red blood cells. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps to support normal growth and development. Helps in energy metabolism and tissue formation. Helps to maintain healthy mucous membranes. Helps to maintain normal metabolism of iron. Helps in energy production. Helps in normal growth.

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Cautions and Warnings : Specific to Lipozene:Take 0.5-1 hour before meals.Taking this product with insufficient liquid may result in choking and/or esophageal blockage/obstruction of the throat, esophagus or intestine.Take 2 hours before or after taking other medications.Consult a healthcare practitioner for use beyond 8 weeks.Consult a health care practitioner prior to use if you are pregnant or breastfeeding or if you have diabetes.Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within seven days.Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis).Do not use if you have difficulty swallowing.If you experience chest pain, vomiting, or difficulty swallowing or breathing after taking the product, seek immediate medical attention.Loose stools, flatulence, diarrhea, and abdominal discomfort have been reported.Store in a dry place at room temperature.Keep out of reach of children.Do not take this product if seal is missing or broken. Specific to MetaboUp Plus:If seal around cap is broken or missing, do not use.For occasional use only.Consult a health care practitioner prior to use if you are pregnant or breastfeeding or taking lithium or have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome) or have a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice) or have an iron deficiency, stomach ulcers or inflammation.Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended.Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended.This product is not intended as a substitute for sleep.Hypersensitivity/allergy is known to occur, in which case, discontinue use.Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. Specific to Lipozene Protein Plus:Ensure to drink enough fluid before, during, and after exercise.Consult a health care practitioner prior to use if you are pregnant or breastfeeding.This product contains milk by-products/derivatives. If you have a milk allergy, do not use this product.

Originaltext auf Englisch.

Produktdaten

Andere Namen
Lipozene Protein Plus Chocolate, Lipozene Protein Plus Vanilla, Lipozene10 Starter Kit, Maximum Strength Lipozene
Inhaber
Obesity Research Institute, LLC
NPN oder DIN-HM
80074007
Status
Lizenz nicht aktiv
Lizenzdatum
24. November 2016
Überarbeitungsdatum
Nicht angegeben
Form
Kit
Verabreichungsweg
Orale
Art des Antrags
Non traditionnelle

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 80074007

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Originaltext auf Französisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Offizielle Warnhinweise (Health Canada)

Health Canada veröffentlicht Warnhinweise zu diesen Zutaten:

  • Capsicum annuum
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    CAYENNE - CAPSICUM ANNUUM Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).

    Von Health Canada zitierte Quellen (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).

    Von Health Canada zitierte Quellen (2)
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).

    Von Health Canada zitierte Quellen (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Anwendungsbedingung: Digestion; Peripheral circulation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Monografie von Health Canada vom 27. März 2026

    CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    For external use only (US FDA 2023).

    Von Health Canada zitierte Quellen (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).

    Von Health Canada zitierte Quellen (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).

    Von Health Canada zitierte Quellen (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 im Text zitierte Studie hat keine passende Angabe im Literaturverzeichnis der Monografie (siehe Auffälligkeiten auf der Quellenseite).

    Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).

    Von Health Canada zitierte Quellen (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).

    Von Health Canada zitierte Quellen (5)
    • APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
    • Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
    • McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomisierte Studie
    • Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematische Übersicht

    Monografie von Health Canada vom 27. März 2026

  • Glucomannane
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    GLUCOMANNAN

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (FDA 2023).

    Von Health Canada zitierte Quellen (1)
    • FDA 2023: United States Food and Drug Administration. Specific Labeling Requirements for Specific Drug Products. Code of Federal Regulations Title 21, Volume 4 (21CFR201.319). Rockville (MD): United States Department of Health and Human Services, U.S. Food and Drug Administration. [Accessed 2023 December 31]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=201.319

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (UpToDate 2023; EMA 2013; Chen et al. 2003; Vuksan et al. 2001).

    Von Health Canada zitierte Quellen (4)
    • Chen HL, Sheu WH, Tai TS, Liaw YP, Chen YC. 2003. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects—a randomized double-blind trial. Journal of American College of Nutrition 22(1):36-42.
    • EMA 2013. European Medicines Agency. Final Community Herbal Monograph on Plantago afra L. et Plantago indica L., semen. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 14 May 2013. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-plantago-afra-l-et-plantago-indica-l-semen_en.pdf
    • UpToDate 2023: Wolters Kluwer. [Accessed 2023 December 31]. Available from: https://www.wolterskluwer.com/en/solutions/uptodate
    • Vuksan V, Sievenpiper JL, Xu Z, Wong EYY, Jenkins AL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Stavro M.P. 2001. Konjac-mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus. Journal of the American College of Nutrition 20:370S-380S.

    Anwendungsbedingung: Laxative; Promotion of bowel movement; Constipation relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Von Health Canada zitierte Quellen (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky C, editor. 2002. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Gegenanzeigen

    Anwendungsbedingung: All products.

    Do not use if you have difficulty swallowing (FDA 2023; Sweetman 2007; Vanderbeek et al. 2007; Henry et al. 1986).

    Von Health Canada zitierte Quellen (5)
    • FDA 2023: United States Food and Drug Administration. Specific Labeling Requirements for Specific Drug Products. Code of Federal Regulations Title 21, Volume 4 (21CFR201.319). Rockville (MD): United States Department of Health and Human Services, U.S. Food and Drug Administration. [Accessed 2023 December 31]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=201.319
    • Henry DA, Mitchell AS, Aylward J. 1986. Glucomannan and risk of esophageal obstruction. British Medical Journal 292:591-592.
    • Sweetman SC, editor. 2007. Martindale: The Complete Drug Reference, 35th edition. London (GB): Pharmaceutical Press.
    • Vanderbeek PB, Fasano C, O'Malley G, Hornstein J. 2007. Esophageal obstruction from a pharmacobezoar containing glucomannan. Clinical Toxicology 45(1):80-82.
    • EMA 2013. European Medicines Agency. Final Community Herbal Monograph on Plantago afra L. et Plantago indica L., semen. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 14 May 2013. [Consulté le 31 décembre 2023]. Disponible à : https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-plantago-afra-l-et-plantago-indica-l-semen_en.pdf

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2013; Pray 2006; Berardi et al. 2002).

    Von Health Canada zitierte Quellen (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. 2002. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association.
    • EMA 2013. European Medicines Agency. Final Community Herbal Monograph on Plantago afra L. et Plantago indica L., semen. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 14 May 2013. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-plantago-afra-l-et-plantago-indica-l-semen_en.pdf
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2013).

    Von Health Canada zitierte Quellen (1)
    • EMA 2013. European Medicines Agency. Final Community Herbal Monograph on Plantago afra L. et Plantago indica L., semen. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 14 May 2013. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-plantago-afra-l-et-plantago-indica-l-semen_en.pdf

    When using this product you may experience temporary gas and bloating (Sood et al. 2008).

    Von Health Canada zitierte Quellen (1)
    • Sood N, Baker WL, Coleman CI. 2008. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. American Journal of Clinical Nutrition 88(4):1167-1175.

    Monografie von Health Canada vom 26. Juli 2024

  • Vitamine D
    Warnhinweis, Geltungsbedingung und zitierte Studien lesen

    Offizieller Originaltext auf Englisch.

    VITAMIN D (>1,000 - 2,500 IU)

    Art der Anwendung: Oral

    Vorsichtsmaßnahmen und Warnhinweise

    Anwendungsbedingung: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Anwendungsbedingung: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Von Health Canada zitierte Quellen (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Gilt für Produkte: containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Gilt für Produkte: providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Gegenanzeigen

    Anwendungsbedingung: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Gilt für Produkte: containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Bekannte Nebenwirkungen

    Anwendungsbedingung: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Von Health Canada zitierte Quellen (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Gilt für Produkte: providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Von Health Canada zitierte Quellen (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Monografie von Health Canada vom 26. Juni 2026

Sie betreffen die Zutat, nicht dieses Produkt oder seine Dosis. Sie ersetzen keinen ärztlichen Rat.

Das Belegdatum dieser Zutatenliste ist unbekannt.

Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.

Eingabetaste zum Analysieren, Umschalt+Eingabetaste für eine neue Zeile